Global Panic Disorders Market Trend and Development Strategy Analysis 2023-2029
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Market Analysis and Insights: Global Panic Disorders Market
The global Panic Disorders market size in 2022 is 9580.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 4.06% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Panic Disorders market include Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Ltd. (India), Mylan N.V. (U.S.), AstraZeneca (U.K.), and Abbott. (U.S.). The share of the top 3 players in the Panic Disorders market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Panic Disorders market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Agoraphobia accounted for XX% of Panic Disorders market in 2022. Social Anxiety Disorder (SAD) share of XX%.
Oral accounted for XX% of the Panic Disorders market in 2022. Parenteral accounts for XX%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Panic Disorders market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Panic Disorders market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Panic Disorders market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Panic Disorders market.
Global Panic Disorders Scope and Market Size
Panic Disorders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Panic Disorders market will be able to gain the upper hand as they use the report as a powerful resource.
The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Panic Disorders industry is considered in the report, covering the dynamic analysis of the development of the Panic Disorders industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some prominent players in the market includes:
Teva Pharmaceutical Industries Ltd. (Israel)
Sun Pharmaceutical Industries Ltd. (India)
Mylan N.V. (U.S.)
AstraZeneca (U.K.)
Abbott. (U.S.)
Baxter. (U.S.)
Bristol-Myers Squibb Company (U.S.)
Eli Lilly and Company. (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
GlaxoSmithKline plc (U.K.)
Noven Pharmaceuticals, Inc. (U.S.)
Pfizer Inc. (U.S.)
Recordati S.p.A. (Italy)
Shionogi & Co., Ltd. (Japan)
Sumitomo Pharma Co., Ltd (Japan)
Boehringer Ingelheim International GmbH. (Germany)
Bausch Health Companies Inc. (Canada)
H. Lundbeck A/S (Denmark)
Sanofi (France)
Neurocrine Biosciences, Inc (U.S.)
Market Data Breakdown by Type
Agoraphobia
Social Anxiety Disorder (SAD)
Obsessive-Compulsive Disorder (OCD)
Bipolar Disorder
Post-Traumatic Stress Disorder (PTSD)
Specific Phobias
Generalized Anxiety Disorder (GAD)
Major Depressive Disorder (MDD)
Market Data Breakdown by Applications
Oral
Parenteral
Others
Table of Content
1 Panic Disorders Market Introduction and Overview
1.1 Panic Disorders Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Panic Disorders Industry Dynamic Analysis
1.5.1 Panic Disorders Market Trends Analysis
1.5.2 Panic Disorders Market Drivers Analysis
1.5.3 Panic Disorders Market Challenges Analysis
1.5.4 Panic Disorders Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Panic Disorders Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Panic Disorders Revenue and Share by Type
3 Global Panic Disorders Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Panic Disorders Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Panic Disorders Market Size (2018-2023)
4.2 Panic Disorders Growth Insights by Regions
4.2.1 Panic Disorders Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Panic Disorders Revenue Market Size by Regions (2018-2023)
4.2.3 North America Panic Disorders Market Size (2018-2023)
4.2.4 Europe Panic Disorders Market Size (2018-2023)
4.2.5 Asia-Pacific Panic Disorders Market Size (2018-2023)
4.2.6 Latin America Panic Disorders Market Size (2018-2023)
4.2.7 Middle East & Africa Panic Disorders Market Size (2018-2023)
5 North America
5.1 North America Panic Disorders Revenue by Countries
5.1.1 North America Panic Disorders Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Panic Disorders Revenue by Countries
6.1.1 Asia Pacific Panic Disorders Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Panic Disorders Revenue by Countries
7.1.1 Europe Panic Disorders Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Panic Disorders Revenue by Countries
8.1.1 Latin America Panic Disorders Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Panic Disorders Revenue by Countries
9.1.1 Middle East & Africa Panic Disorders Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Panic Disorders Market Competition, by Players
10.1 Global Panic Disorders Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Panic Disorders Players Market Share in 2022
10.2.2 Top 6 Panic Disorders Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Panic Disorders Players Head Office, Business Provided
10.4 Panic Disorders Mergers & Acquisitions
10.5 Panic Disorders New Entrants and Expansion Plans
11 Players Profiles
11.1 Teva Pharmaceutical Industries Ltd. (Israel)
11.1.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Profile
11.1.2 Panic Disorders Product Overview
11.1.3 Teva Pharmaceutical Industries Ltd. (Israel) Panic Disorders Market Performance (2018-2023)
11.1.4 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
11.1.5 Recent Developments and Plans
11.2 Sun Pharmaceutical Industries Ltd. (India)
11.2.1 Sun Pharmaceutical Industries Ltd. (India) Company Profile
11.2.2 Panic Disorders Product Overview
11.2.3 Sun Pharmaceutical Industries Ltd. (India) Panic Disorders Market Performance (2018-2023)
11.2.4 Sun Pharmaceutical Industries Ltd. (India) Business Overview
11.2.5 Recent Developments and Plans
11.3 Mylan N.V. (U.S.)
11.3.1 Mylan N.V. (U.S.) Company Profile
11.3.2 Panic Disorders Product Overview
11.3.3 Mylan N.V. (U.S.) Panic Disorders Market Performance (2018-2023)
11.3.4 Mylan N.V. (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 AstraZeneca (U.K.)
11.4.1 AstraZeneca (U.K.) Company Profile
11.4.2 Panic Disorders Product Overview
11.4.3 AstraZeneca (U.K.) Panic Disorders Market Performance (2018-2023)
11.4.4 AstraZeneca (U.K.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Abbott. (U.S.)
11.5.1 Abbott. (U.S.) Company Profile
11.5.2 Panic Disorders Product Overview
11.5.3 Abbott. (U.S.) Panic Disorders Market Performance (2018-2023)
11.5.4 Abbott. (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 Baxter. (U.S.)
11.6.1 Baxter. (U.S.) Company Profile
11.6.2 Panic Disorders Product Overview
11.6.3 Baxter. (U.S.) Panic Disorders Market Performance (2018-2023)
11.6.4 Baxter. (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Bristol-Myers Squibb Company (U.S.)
11.7.1 Bristol-Myers Squibb Company (U.S.) Company Profile
11.7.2 Panic Disorders Product Overview
11.7.3 Bristol-Myers Squibb Company (U.S.) Panic Disorders Market Performance (2018-2023)
11.7.4 Bristol-Myers Squibb Company (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 Eli Lilly and Company. (U.S.)
11.8.1 Eli Lilly and Company. (U.S.) Company Profile
11.8.2 Panic Disorders Product Overview
11.8.3 Eli Lilly and Company. (U.S.) Panic Disorders Market Performance (2018-2023)
11.8.4 Eli Lilly and Company. (U.S.) Business Overview
11.8.5 Recent Developments and Plans
11.9 F. Hoffmann-La Roche Ltd (Switzerland)
11.9.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
11.9.2 Panic Disorders Product Overview
11.9.3 F. Hoffmann-La Roche Ltd (Switzerland) Panic Disorders Market Performance (2018-2023)
11.9.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
11.9.5 Recent Developments and Plans
11.10 GlaxoSmithKline plc (U.K.)
11.10.1 GlaxoSmithKline plc (U.K.) Company Profile
11.10.2 Panic Disorders Product Overview
11.10.3 GlaxoSmithKline plc (U.K.) Panic Disorders Market Performance (2018-2023)
11.10.4 GlaxoSmithKline plc (U.K.) Business Overview
11.10.5 Recent Developments and Plans
11.11 Noven Pharmaceuticals, Inc. (U.S.)
11.11.1 Noven Pharmaceuticals, Inc. (U.S.) Company Profile
11.11.2 Panic Disorders Product Overview
11.11.3 Noven Pharmaceuticals, Inc. (U.S.) Panic Disorders Market Performance (2018-2023)
11.11.4 Noven Pharmaceuticals, Inc. (U.S.) Business Overview
11.11.5 Recent Developments and Plans
11.12 Pfizer Inc. (U.S.)
11.12.1 Pfizer Inc. (U.S.) Company Profile
11.12.2 Panic Disorders Product Overview
11.12.3 Pfizer Inc. (U.S.) Panic Disorders Market Performance (2018-2023)
11.12.4 Pfizer Inc. (U.S.) Business Overview
11.12.5 Recent Developments and Plans
11.13 Recordati S.p.A. (Italy)
11.13.1 Recordati S.p.A. (Italy) Company Profile
11.13.2 Panic Disorders Product Overview
11.13.3 Recordati S.p.A. (Italy) Panic Disorders Market Performance (2018-2023)
11.13.4 Recordati S.p.A. (Italy) Business Overview
11.13.5 Recent Developments and Plans
11.14 Shionogi & Co., Ltd. (Japan)
11.14.1 Shionogi & Co., Ltd. (Japan) Company Profile
11.14.2 Panic Disorders Product Overview
11.14.3 Shionogi & Co., Ltd. (Japan) Panic Disorders Market Performance (2018-2023)
11.14.4 Shionogi & Co., Ltd. (Japan) Business Overview
11.14.5 Recent Developments and Plans
11.15 Sumitomo Pharma Co., Ltd (Japan)
11.15.1 Sumitomo Pharma Co., Ltd (Japan) Company Profile
11.15.2 Panic Disorders Product Overview
11.15.3 Sumitomo Pharma Co., Ltd (Japan) Panic Disorders Market Performance (2018-2023)
11.15.4 Sumitomo Pharma Co., Ltd (Japan) Business Overview
11.15.5 Recent Developments and Plans
11.16 Boehringer Ingelheim International GmbH. (Germany)
11.16.1 Boehringer Ingelheim International GmbH. (Germany) Company Profile
11.16.2 Panic Disorders Product Overview
11.16.3 Boehringer Ingelheim International GmbH. (Germany) Panic Disorders Market Performance (2018-2023)
11.16.4 Boehringer Ingelheim International GmbH. (Germany) Business Overview
11.16.5 Recent Developments and Plans
11.17 Bausch Health Companies Inc. (Canada)
11.17.1 Bausch Health Companies Inc. (Canada) Company Profile
11.17.2 Panic Disorders Product Overview
11.17.3 Bausch Health Companies Inc. (Canada) Panic Disorders Market Performance (2018-2023)
11.17.4 Bausch Health Companies Inc. (Canada) Business Overview
11.17.5 Recent Developments and Plans
11.18 H. Lundbeck A/S (Denmark)
11.18.1 H. Lundbeck A/S (Denmark) Company Profile
11.18.2 Panic Disorders Product Overview
11.18.3 H. Lundbeck A/S (Denmark) Panic Disorders Market Performance (2018-2023)
11.18.4 H. Lundbeck A/S (Denmark) Business Overview
11.18.5 Recent Developments and Plans
11.19 Sanofi (France)
11.19.1 Sanofi (France) Company Profile
11.19.2 Panic Disorders Product Overview
11.19.3 Sanofi (France) Panic Disorders Market Performance (2018-2023)
11.19.4 Sanofi (France) Business Overview
11.19.5 Recent Developments and Plans
11.20 Neurocrine Biosciences, Inc (U.S.)
11.20.1 Neurocrine Biosciences, Inc (U.S.) Company Profile
11.20.2 Panic Disorders Product Overview
11.20.3 Neurocrine Biosciences, Inc (U.S.) Panic Disorders Market Performance (2018-2023)
11.20.4 Neurocrine Biosciences, Inc (U.S.) Business Overview
11.20.5 Recent Developments and Plans
12 Global Panic Disorders Forecast Market Insights by Type
12.1 Global Panic Disorders Revenue Market Forecast by Type (2023-2029)
13 Global Panic Disorders Forecast Market Insights by Application
13.1 Panic Disorders Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Panic Disorders Forecast Market Size (2023-2029)
14.2 Panic Disorders Growth Forecast Insights by Regions
14.2.1 Panic Disorders Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Panic Disorders Forecast Market Size (2023-2029)
14.2.3 Europe Panic Disorders Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Panic Disorders Forecast Market Size (2023-2029)
14.2.5 Latin America Panic Disorders Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Panic Disorders Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer
Tables & Figures:
List of Tables and Figures
Figure Panic Disorders Picture
Table Product Definition of Panic Disorders
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Panic Disorders Market Size by Type (2018 VS 2023 VS 2029)
Table Global Panic Disorders Revenue by Type (2018-2023)
Table Global Panic Disorders Revenue and Share by Type (2018-2023)
Table Global Panic Disorders Market Size by Application (2018 VS 2023 VS 2029)
Table Global Panic Disorders Revenue by Application (2018-2023)
Table Global Panic Disorders Revenue Share by Application (2018-2023)
Figure Global Panic Disorders Revenue Market Size Growth (2018-2023)
Table Panic Disorders Market Size by Regions: 2018 VS 2023 VS 2029
Table Panic Disorders Revenue Market Size by Regions (2018-2023)
Table Panic Disorders Revenue and Share by Regions (2018-2023)
Figure North America Panic Disorders Market Size (2018-2023)
Figure Europe Panic Disorders Market Size (2018-2023)
Figure Asia-Pacific Panic Disorders Market Size (2018-2023)
Figure Latin America Panic Disorders Market Size (2018-2023)
Figure Middle East & Africa Panic Disorders Market Size (2018-2023)
Table North America Panic Disorders Revenue by Countries (2018-2023)
Table North America Panic Disorders Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States Panic Disorders Revenue and Growth (2018-2023)
Figure Canada Panic Disorders Revenue and Growth (2018-2023)
Figure Canada Panic Disorders Sales and Growth (2018-2023)
Table Asia-Pacific Panic Disorders Revenue by Countries (2018-2023)
Table Asia-Pacific Panic Disorders Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China Panic Disorders Revenue and Growth (2018-2023)
Figure Japan Panic Disorders Revenue and Growth (2018-2023)
Figure Korea Panic Disorders Revenue and Growth (2018-2023)
Figure Southeast Asia Panic Disorders Revenue and Growth (2018-2023)
Figure India Panic Disorders Revenue and Growth (2018-2023)
Figure Australia Panic Disorders Revenue and Growth (2018-2023)
Table Europe Panic Disorders Revenue by Countries (2018-2023)
Table Europe Panic Disorders Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany Panic Disorders Revenue and Growth (2018-2023)
Figure France Panic Disorders Revenue and Growth (2018-2023)
Figure UK Panic Disorders Revenue and Growth (2018-2023)
Figure Italy Panic Disorders Revenue and Growth (2018-2023)
Figure Russia Panic Disorders Revenue and Growth (2018-2023)
Figure Spain Panic Disorders Revenue and Growth (2018-2023)
Figure Nordic Panic Disorders Revenue and Growth (2018-2023)
Table Latin America Panic Disorders Revenue by Countries (2018-2023)
Table Latin America Panic Disorders Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil Panic Disorders Revenue and Growth (2018-2023)
Figure Argentina Panic Disorders Revenue and Growth (2018-2023)
Figure Mexico Panic Disorders Revenue and Growth (2018-2023)
Table Middle East & Africa Panic Disorders Revenue by Countries (2018-2023)
Table Middle East & Africa Panic Disorders Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt Panic Disorders Revenue and Growth (2018-2023)
Figure South Africa Panic Disorders Revenue and Growth (2018-2023)
Figure UAE Panic Disorders Revenue and Growth (2018-2023)
Figure Turkey Panic Disorders Revenue and Growth (2018-2023)
Figure Saudi Arabia Panic Disorders Revenue and Growth (2018-2023)
Table Global Panic Disorders Revenue by Players (2018-2023)
Table Global Panic Disorders Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Panic Disorders Players Market Concentration Ratio (CR5) (2018-2023)
Table Panic Disorders Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Teva Pharmaceutical Industries Ltd. (Israel) Profile
Table Product Overview
Table Teva Pharmaceutical Industries Ltd. (Israel) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Teva Pharmaceutical Industries Ltd. (Israel) Revenue and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. (Israel) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Sun Pharmaceutical Industries Ltd. (India) Profile
Table Product Overview
Table Sun Pharmaceutical Industries Ltd. (India) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Sun Pharmaceutical Industries Ltd. (India) Revenue and Growth Rate
Figure Sun Pharmaceutical Industries Ltd. (India) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Mylan N.V. (U.S.) Profile
Table Product Overview
Table Mylan N.V. (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Mylan N.V. (U.S.) Revenue and Growth Rate
Figure Mylan N.V. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table AstraZeneca (U.K.) Profile
Table Product Overview
Table AstraZeneca (U.K.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure AstraZeneca (U.K.) Revenue and Growth Rate
Figure AstraZeneca (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Abbott. (U.S.) Profile
Table Product Overview
Table Abbott. (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Abbott. (U.S.) Revenue and Growth Rate
Figure Abbott. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Baxter. (U.S.) Profile
Table Product Overview
Table Baxter. (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Baxter. (U.S.) Revenue and Growth Rate
Figure Baxter. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bristol-Myers Squibb Company (U.S.) Profile
Table Product Overview
Table Bristol-Myers Squibb Company (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Bristol-Myers Squibb Company (U.S.) Revenue and Growth Rate
Figure Bristol-Myers Squibb Company (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Eli Lilly and Company. (U.S.) Profile
Table Product Overview
Table Eli Lilly and Company. (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Eli Lilly and Company. (U.S.) Revenue and Growth Rate
Figure Eli Lilly and Company. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table F. Hoffmann-La Roche Ltd (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd (Switzerland) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GlaxoSmithKline plc (U.K.) Profile
Table Product Overview
Table GlaxoSmithKline plc (U.K.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure GlaxoSmithKline plc (U.K.) Revenue and Growth Rate
Figure GlaxoSmithKline plc (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Noven Pharmaceuticals, Inc. (U.S.) Profile
Table Product Overview
Table Noven Pharmaceuticals, Inc. (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Noven Pharmaceuticals, Inc. (U.S.) Revenue and Growth Rate
Figure Noven Pharmaceuticals, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Pfizer Inc. (U.S.) Profile
Table Product Overview
Table Pfizer Inc. (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Revenue and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Recordati S.p.A. (Italy) Profile
Table Product Overview
Table Recordati S.p.A. (Italy) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Recordati S.p.A. (Italy) Revenue and Growth Rate
Figure Recordati S.p.A. (Italy) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Shionogi & Co., Ltd. (Japan) Profile
Table Product Overview
Table Shionogi & Co., Ltd. (Japan) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Shionogi & Co., Ltd. (Japan) Revenue and Growth Rate
Figure Shionogi & Co., Ltd. (Japan) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Sumitomo Pharma Co., Ltd (Japan) Profile
Table Product Overview
Table Sumitomo Pharma Co., Ltd (Japan) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Sumitomo Pharma Co., Ltd (Japan) Revenue and Growth Rate
Figure Sumitomo Pharma Co., Ltd (Japan) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Boehringer Ingelheim International GmbH. (Germany) Profile
Table Product Overview
Table Boehringer Ingelheim International GmbH. (Germany) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Boehringer Ingelheim International GmbH. (Germany) Revenue and Growth Rate
Figure Boehringer Ingelheim International GmbH. (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bausch Health Companies Inc. (Canada) Profile
Table Product Overview
Table Bausch Health Companies Inc. (Canada) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Bausch Health Companies Inc. (Canada) Revenue and Growth Rate
Figure Bausch Health Companies Inc. (Canada) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table H. Lundbeck A/S (Denmark) Profile
Table Product Overview
Table H. Lundbeck A/S (Denmark) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure H. Lundbeck A/S (Denmark) Revenue and Growth Rate
Figure H. Lundbeck A/S (Denmark) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Sanofi (France) Profile
Table Product Overview
Table Sanofi (France) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Sanofi (France) Revenue and Growth Rate
Figure Sanofi (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Neurocrine Biosciences, Inc (U.S.) Profile
Table Product Overview
Table Neurocrine Biosciences, Inc (U.S.) Panic Disorders Revenue, Gross and Gross Margin (2018-2023)
Figure Neurocrine Biosciences, Inc (U.S.) Revenue and Growth Rate
Figure Neurocrine Biosciences, Inc (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Panic Disorders Revenue Forecast by Type (2023-2029)
Table Global Panic Disorders Revenue and Share Forecast by Type (2023-2029)
Table Global Panic Disorders Revenue by Application (2023-2029)
Table Global Panic Disorders Revenue and Share by Application (2023-2029)
Figure Global Panic Disorders Revenue Forecast Market Size (2023-2029)
Table Panic Disorders Revenue Forecast by Regions (2023-2029)
Table Panic Disorders Revenue and Share Forecast by Regions (2023-2029)
Figure North America Panic Disorders Revenue Forecast Market Size (2023-2029)
Figure Europe Panic Disorders Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Panic Disorders Revenue Forecast Market Size (2023-2029)
Figure Latin America Panic Disorders Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Panic Disorders Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Research Methodology:
Global Panic Disorders Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|